UnknownNot Applicable

Brimonidine in Rosacea

45 participantsStarted 2022-05-25

Plain-language summary

Rosacea is a chronic and relapsing inflammatory cutaneous disorder with highly variable prevalence worldwide.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with current erythematotelangiectatic rosacea Exclusion Criteria: \- Pregnant females. 2-Patients on systemic steroids. 3-Patients complaining of other dermatological disorders mainly photosensitive cutaneous disorder. 4- Patients receiving any systemic treatment including retinoids for the previous 1 month or any topical treatment for the previous 2 weeks or any laser sessions for the previous 3months for erythematotelangiectatic rosacea at least.

What they're measuring

Clinical erythema assessment scale

Timeframe: 3 months

Trial details

NCT IDNCT05401422

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-15

View on ClinicalTrials.gov More Rosacea trials